Chlamydia trachomatis is an important human pathogen. Research to develop a Chlamydia
vaccine has focused on the major outer membrane protein (MOMP). Determinants of this …

Because partial protection against reinfection is induced by experimental infection in the
guinea-pig model of genital chlamydial infection, we sought to induce immunity by …

The antigenically variant Chlamydia trachomatis major outer membrane protein (MOMP) is a
target of antibody-mediated neutralization in vitro, and it is an important protein for designing …

A vaccine is likely the most effective strategy for controlling human chlamydial infections.
Recent studies have shown immunization with Chlamydia muridarum major outer …

Studies using the guinea pig model of chlamydial genital infection with the Chlamydia
psittaci agent of guinea pig inclusion conjunctivitis (GPIC) have shown that serum and local …

Objectives To test vaccines, formulated with novel antigens, to protect mice against
Chlamydia infections. Methods To determine the ability of polymorphic membrane proteins …

2 METHODS 2.1 Protein Purification Elementary bodies (EBS) of the Chlamydia psittaci
agent guinea pig inclusion conjunctivitis (GPIC) were produced by growth in McCoy cell …

We cloned and sequenced the gene encoding the major outer membrane protein (MOMP) of
two Chlamydia psittaci strains, guinea pig inclusion conjunctivitis (GPIC) strain 1, and …

The Chlamydial outer membrane complex (COMC) from the elementary body (EB) is a
protein rich insoluble outer membrane shell from which cytosolic proteins have been …

Chlamydia trachomatis serovars A, B, and C are the causative agents of trachoma, the
world's leading cause of preventable blindness. Immunoprophylaxis is a possible approach …